Lista de obras -

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer

artículo científico publicado en 2015

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

artículo científico publicado en 2019

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

scientific article published on 03 November 2019

CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples

scientific article published on 18 October 2019

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies

artículo científico publicado en 2015

Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients

article

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique.

artículo científico publicado en 2017

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.

artículo científico publicado en 2017

Letter to the editor concerning first-line therapy with afatinib - an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations.

artículo científico publicado en 2015

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

artículo científico publicado en 2020

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.

artículo científico publicado en 2012

Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.

artículo científico publicado en 2015

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer.

artículo científico publicado en 2019

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

scientific article published on 08 June 2019

PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

artículo científico publicado en 2016

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer.

artículo científico publicado en 2017

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

artículo científico publicado en 2015

Preventing central nervous system metastases in non-small cell lung cancer

artículo científico publicado en 2018

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients

scientific article published on 03 December 2019

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report

artículo científico publicado en 2014

Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer

artículo científico publicado en 2016

Screening for gene mutations in central nervous system metastases of non-small-cell lung cancer

artículo científico publicado en 2018

Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer

artículo científico publicado en 2014

Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer

artículo científico publicado en 2016

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study

artículo científico publicado en 2021

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

artículo científico publicado en 2020

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.

artículo científico publicado en 2013

The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy

artículo científico publicado en 2013

Lista de obras de

Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer

Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples

Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies

Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients

Evaluation of ALK gene rearrangement in central nervous system metastases of non-small-cell lung cancer using two-step RT-PCR technique.

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.

Letter to the editor concerning first-line therapy with afatinib - an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations.

Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.

Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.

MicroRNAs aid the assessment of programmed death ligand 1 expression in patients with non-small cell lung cancer.

PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients

PIK3CA Mutations Detected in Patients with Central Nervous System Metastases of Non-small Cell Lung Cancer

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

Preventing central nervous system metastases in non-small cell lung cancer

Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report

Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer

Screening for gene mutations in central nervous system metastases of non-small-cell lung cancer

Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer

Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer

The Correlation of Mutations and Expressions of Genes within the PI3K/Akt/mTOR Pathway in Breast Cancer-A Preliminary Study

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma.

The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy